4575 — CanBas Co Share Price
0.000.00%
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.21 | ||
| Price to Tang. Book | 6.21 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -53.5% | ||
| Return on Equity | -46.08% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Jun | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 108.94 | n/a | n/a | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CanBas Co Ltd is a Japan-based company mainly engaged in pharmaceutical business. It is a drug discovery venture company engaged in basic research and clinical development of anticancer drugs. Its basic research on anticancer drugs includes examining drug discovery concepts, selecting drug candidate compounds using methods based on those concepts, simple animal testing, and collecting and analyzing basic data on anticancer drug candidate compounds that have already progressed to the development stage. It is engaged in early clinical development (preclinical trials and the first half of clinical trials conducted immediately before applying for clinical trial initiation) and late clinical development (the second half of clinical trials aimed at applying for new drug approval). Its development pipelines include CBP501, CBS9106, and follow-on pipelines such as CBT005, CBP-A08 and IDO/TDO inhibitor.
Directors
- Last Annual
- June 30th, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- January 18th, 2000
- Public Since
- September 17th, 2009
- No. of Shareholders
- 13,689
- No. of Employees
- 14
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 19,703,057
- Address
- 2-2-1, Ote-machi, NUMAZU-SHI, 410-0801
- Web
- https://www.canbas.co.jp/
- Phone
- +81 559543666
- Auditors
- Deloitte Touche Tohmatsu LLC
Upcoming Events for 4575
Dividend For 4575.T - 0.0000 JPY
Similar to 4575
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
CellSource Co
Tokyo Stock Exchange
FAQ
What is the CanBas Co share price?
As of Today at 19:48 UTC, shares in CanBas Co are trading at ¥749. This share price information is delayed by 15 minutes.
How has the CanBas Co share price performed this year?
Shares in CanBas Co last closed at ¥749 and the price had moved by -19.64% over the past 365 days. In terms of relative price strength the CanBas Co share price has underperformed the Nikkei 225 Index by -47.45% over the past year.
What are the analyst and broker recommendations for CanBas Co?
There is no consensus recommendation for this security.
Find out moreWhat is the CanBas Co dividend yield?
CanBas Co does not currently pay a dividend.
Does CanBas Co pay a dividend?
CanBas Co does not currently pay a dividend.
When does CanBas Co next pay dividends?
CanBas Co does not currently pay a dividend.
How do I buy CanBas Co shares?
To buy shares in CanBas Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CanBas Co?
As of the previous close price of ¥749, shares in CanBas Co had a market capitalisation of ¥15bn.
Where are CanBas Co shares listed?
Here are the trading details for CanBas Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4575
What kind of share is CanBas Co?
Based on an overall assessment of its quality, value and momentum CanBas Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CanBas Co share price forecast for 2026?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the CanBas Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CanBas Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -34.81%.
As of the last closing price of ¥749, shares in CanBas Co were trading -20.75% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CanBas Co PE Ratio?
The CanBas Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥749.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CanBas Co?
CanBas Co's management team is headed by:
- Takumi Kawabe - PRE
- Makoto Katozumi - CFO
- Toshiyuki Hibino - COO
- Kazuyoshi Sakamoto - OTH